Luc Xerri

Marseille, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications

Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.

Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.

Journal: Blood
Published: January 13, 2026

Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.

Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.

Journal: Blood
Published: January 13, 2026

Follicular and follicle center-cell lymphomas: A family between kinship and diversity

Follicular and follicle center-cell lymphomas: A family between kinship and diversity

Journal: Annales de pathologie
Published: January 07, 2026

Updates in marginal zone lymphomas

Updates in marginal zone lymphomas

Journal: Annales de pathologie
Published: January 06, 2026

Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.

Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.

Journal: Leukemia
Published: November 20, 2025

Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.

Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.

Journal: Leukemia
Published: July 28, 2025

Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.

Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.

Journal: Blood cancer journal
Published: June 13, 2025

Mutation profiling in differential diagnosis between TdT-positive high-grade/large B-cell lymphoma and B-lymphoblastic leukaemia/lymphoma.

Mutation profiling in differential diagnosis between TdT-positive high-grade/large B-cell lymphoma and B-lymphoblastic leukaemia/lymphoma.

Journal: The Journal of pathology
Published: April 18, 2025

Distribution reappraisal of peripheral T- and NK-cell lymphoma entities through the French Lymphopath network database.

Distribution reappraisal of peripheral T- and NK-cell lymphoma entities through the French Lymphopath network database.

Journal: HemaSphere
Published: April 15, 2025

Comparative DNA Methylation Profiling of Human and Murine ALK-Positive B-Cell Neoplasms.

Comparative DNA Methylation Profiling of Human and Murine ALK-Positive B-Cell Neoplasms.

Journal: Genes, chromosomes & cancer
Published: February 24, 2025

Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatment.

Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatment.

Journal: Blood
Published: November 18, 2024

Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept.

Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept.

Journal: Leukemia
Published: November 18, 2024
Showing 1-12 of 80

Last Updated: 09/26/2026